LTS LOHMANN Therapie-Systeme AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 1984-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.ltslohmann.de
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
8
PHILIPPINES:7
NMPA:1
Drug Approvals
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字J20130125
- Approval Date
- Dec 25, 2019
NMPA
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)
Phase 1
Completed
- Conditions
- Gastroretentive Drug Formulation of FurosemideOedema
- Interventions
- First Posted Date
- 2013-06-26
- Last Posted Date
- 2013-12-12
- Lead Sponsor
- LTS Lohmann Therapie-Systeme AG
- Target Recruit Count
- 10
- Registration Number
- NCT01887379
- Locations
- 🇩🇪
SocraTec R&D GmbH Clinical Pharmacology Unit, Berlin, Germany
News
LTS and Nualtis Form Strategic Partnership to Scale Oral Thin Film Drug Delivery Manufacturing
LTS LOHMANN Therapie-Systeme AG and Nualtis announced a strategic collaboration to provide robust, high-quality large-scale manufacturing capabilities for oral thin film drug delivery technologies.